Zeroing in on myofascial pain
Myofascial pain syndrome represents the largest group of poorly recognizd and undertreated acuate and chronic medical problems in clinical practice.
Myofascial pain syndrome (MFPS) represents the largest group of poorly recognized and undertreated acute and chronic medical problems in clinical practice.1 Its prevalence is estimated to be approximately 30% among patients seen in general medical clinics and as high as 85% in pain specialty clinics.2-5 The gynecologic literature cites chronic pelvic pain (CPP) as the most common indication for performing operative laparoscopy.6 CPP has been defined as noncyclic pain lasting at least 6 months that localizes to the anatomic pelvis, anterior abdominal wall, the lumbosacral back, or the buttocks and is severe enough to cause functional disability or necessitate medical care.7
What is myofascial pain syndrome?
Key biomarkers for predicting congenital cytomegalovirus
December 26th 2024A new study highlights the prognostic value of thrombocytes, β2-microglobulin, and cytomegalovirus viral load in assessing congenital cytomegalovirus infection, offering insights for improved prenatal counseling.
Read More
EHR-based models show promise in predicting postpartum depression
December 24th 2024Recent research published highlights the potential of electronic health record data to improve postpartum depression diagnosis, offering a step toward better mental health outcomes for birthing parents.
Read More
